Back
MoonLake Immunotherapeutics Stock Predictions
Sponsored
MLTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
MLTX
MoonLake Immunotherapeutics
Last Price:
52.02
Seasonality Move:
36.4%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 87.3% based on the past 4 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $49.82. The Score for MLTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 87.3% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
62
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
37.55
Prediction Charts
Market Cap:
3.14B
Price in USD:
49.82
Volume:
191.04K
Beta:
1.29
Technical Analysis
SMA50:
50.00
SMA100:
47.77
SMA200:
46.96
52-Wk Change:
16.76%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 49.82 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 46.99 | 46.76 | 47.23 | 46.04 |
Nov-4 | 46.37 | 46.40 | 47.46 | 45.27 |
Nov-5 | 47.22 | 47.63 | 48.20 | 45.91 |
Nov-6 | 48.07 | 51.48 | 51.67 | 48.07 |
Nov-7 | 51.98 | 50.67 | 52.34 | 49.60 |
Nov-8 | 50.46 | 51.70 | 52.00 | 50.02 |
Nov-11 | 52.00 | 53.89 | 54.26 | 51.42 |
Nov-12 | 53.72 | 51.80 | 54.81 | 51.51 |
Nov-13 | 52.36 | 51.06 | 53.18 | 50.93 |
Nov-14 | 50.63 | 52.50 | 52.96 | 50.28 |
Nov-15 | 51.98 | 48.83 | 52.24 | 48.30 |
Nov-18 | 48.80 | 48.54 | 49.29 | 47.33 |
Nov-19 | 48.23 | 49.33 | 49.48 | 48.23 |
Nov-20 | 49.44 | 49.82 | 50.98 | 48.97 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.72 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.